NVET
Nexvet Biopharma plc Ordinary Shares
NVET
NVET
Delisted
NVET was delisted on the 28th of July, 2017.
17 hedge funds and large institutions have $23.8M invested in Nexvet Biopharma plc Ordinary Shares in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
17
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$281K | |
| 2 | +$71.6K | |
| 3 | +$13K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3K |
Top Sellers
| 1 | -$332K | |
| 2 | -$53.5K | |
| 3 | -$9.02K | |
| 4 |
Morgan Stanley
New York
|
-$3.35K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$277 |